Claudia Hofmann

Claudia Hofmann is a highly experienced patent agent and intellectual property professional with a diverse background in biotechnology and law. Currently serving as a Patent Agent at BioNTech SE since May 2024, Claudia has previously held significant roles including Director and Associate Director of Intellectual Property at Synlogic from November 2021 to February 2024, and Senior Patent Agent at PureTech Health from August 2018 to November 2021. Claudia's early career includes positions at Synlogic, DT Ward, PC, and Cell Signaling Technology, where skills in both patent law and scientific communication were developed. With a Ph.D. in Biochemistry and Molecular Biology from Boston University and a JD, cum laude, from Suffolk University Law School, Claudia combines advanced scientific expertise with legal knowledge to support innovation in the biotech industry. Claudia's research accomplishments include establishing a transgenic mouse model for vascular occlusive disease and identifying beneficial cardiovascular effects of green tea, complemented by multiple peer-reviewed publications and presentations at international conferences.